Parallel Advisors, LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,532,607
-11.6%
85,3820.0%0.05%
-8.9%
Q2 2023$1,734,108
+11.3%
85,3820.0%0.06%
+5.7%
Q1 2023$1,557,368
-11.6%
85,382
+0.3%
0.05%
-30.3%
Q4 2022$1,761,047
-20.7%
85,157
+0.3%
0.08%
-25.5%
Q3 2022$2,220,000
+3.3%
84,862
+0.0%
0.10%
+3.0%
Q2 2022$2,150,000
-24.1%
84,857
+0.0%
0.10%
-11.6%
Q1 2022$2,833,000
-17.5%
84,828
+0.0%
0.11%
-11.8%
Q4 2021$3,432,000
+15.8%
84,803
-0.2%
0.13%
+6.7%
Q3 2021$2,963,000
+26.6%
84,983
-0.3%
0.12%
+20.2%
Q2 2021$2,340,000
-2.2%
85,2250.0%0.10%
-12.4%
Q1 2021$2,393,000
+8.2%
85,2250.0%0.11%
-5.8%
Q4 2020$2,212,000
+51.4%
85,2250.0%0.12%
+33.3%
Q3 2020$1,461,000
-32.0%
85,225
-1.9%
0.09%
-35.7%
Q2 2020$2,149,000
+76.7%
86,880
-0.8%
0.14%
+42.9%
Q1 2020$1,216,000
+38.7%
87,614
+0.9%
0.10%
+48.5%
Q4 2019$877,000
+12.0%
86,855
+0.9%
0.07%
-1.5%
Q3 2019$783,000
+15560.0%
86,055
+13668.8%
0.07%
Q2 2019$5,0006250.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders